BBB National Programs Newsroom

Advertiser Agrees to Refrain from Claims that Provezza Elderberry Syrup Protects Against COVID-19

For Immediate Release 

Contact: Abby Hills, Director of Communications, BBB National Programs 

301.412.7769 / ahills@bbbnp.org 

 

New York, NY – June 22, 2020 – Provezza Health, LLC informed the National Advertising Division (NAD) that, prior to the opening of NAD’s inquiry, it had permanently discontinued the Instagram post of Provezza Elderberry Syrup with the text, “Potent Immune Support During A Severe Season” and associated text stating “Provezza is highly concentrated to deliver antioxidant action for immune defense” because the advertisement’s publication cycle had ended. While the advertiser disagreed that the post challenged by NAD conveyed the implied claim that Provezza Elderberry Syrup protects users against COVID-19, it committed to refrain from making express or implied claims with such a message in the future.

Through a routine monitoring program, NAD questioned a social media post by Provezza Health, noting that the Federal Trade Commission (FTC) and the U.S. Food and Drug Administration (FDA) have issued dozens of warning letters to dietary supplement manufacturers in response to advertisements touting their products’ abilities to cure or increase consumers’ immunity to protect them from COVID-19. NAD shares the FTC and FDA’s concerns and is using its monitoring resources to find claims for products touting misleading health-conferring benefits related to COVID-19 as part of its public interest mission to protect consumers particularly during this unprecedented time.

NAD appreciated the advertiser’s cooperation and its commitment to avoid making any express or implied claims that promote its products’ ability to protect consumers against COVID-19 in future advertising.

In its advertiser’s statement, Provezza Health thanked NAD for “its ongoing monitoring efforts of the dietary supplement industry” and stated that it has “never expressly or impliedly claimed to treat COVID-19 or any other disease, and we will continue this policy in the future.”

This release was updated on June 26, 2020. Contact Abby Hills with questions. 

 

### 

About the National Advertising Division: National Advertising Division (NAD), a division of BBB National Programs, provides independent self-regulation overseeing the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for truth and accuracy.  

About BBB National Programs: BBB National Programs fosters trust, innovation, and competition in the marketplace through the development and delivery of cost-effective, third-party self-regulation, dispute resolution and other programs. BBB National Programs is the home of industry self-regulatory and dispute resolution programs designed to resolve business issues and advance shared objectives by responding to marketplace concerns to create a better customer experience. To learn more about industry self-regulation, please visit: BBBNP.org

Advertiser Agrees to Refrain from Claims that Provezza Elderberry Syrup Protects Against COVID-19

For Immediate Release 

Contact: Abby Hills, Director of Communications, BBB National Programs 

301.412.7769 / ahills@bbbnp.org 

 

New York, NY – June 22, 2020 – Provezza Health, LLC informed the National Advertising Division (NAD) that, prior to the opening of NAD’s inquiry, it had permanently discontinued the Instagram post of Provezza Elderberry Syrup with the text, “Potent Immune Support During A Severe Season” and associated text stating “Provezza is highly concentrated to deliver antioxidant action for immune defense” because the advertisement’s publication cycle had ended. While the advertiser disagreed that the post challenged by NAD conveyed the implied claim that Provezza Elderberry Syrup protects users against COVID-19, it committed to refrain from making express or implied claims with such a message in the future.

Through a routine monitoring program, NAD questioned a social media post by Provezza Health, noting that the Federal Trade Commission (FTC) and the U.S. Food and Drug Administration (FDA) have issued dozens of warning letters to dietary supplement manufacturers in response to advertisements touting their products’ abilities to cure or increase consumers’ immunity to protect them from COVID-19. NAD shares the FTC and FDA’s concerns and is using its monitoring resources to find claims for products touting misleading health-conferring benefits related to COVID-19 as part of its public interest mission to protect consumers particularly during this unprecedented time.

NAD appreciated the advertiser’s cooperation and its commitment to avoid making any express or implied claims that promote its products’ ability to protect consumers against COVID-19 in future advertising.

In its advertiser’s statement, Provezza Health thanked NAD for “its ongoing monitoring efforts of the dietary supplement industry” and stated that it has “never expressly or impliedly claimed to treat COVID-19 or any other disease, and we will continue this policy in the future.”

This release was updated on June 26, 2020. Contact Abby Hills with questions. 

 

### 

About the National Advertising Division: National Advertising Division (NAD), a division of BBB National Programs, provides independent self-regulation overseeing the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for truth and accuracy.  

About BBB National Programs: BBB National Programs fosters trust, innovation, and competition in the marketplace through the development and delivery of cost-effective, third-party self-regulation, dispute resolution and other programs. BBB National Programs is the home of industry self-regulatory and dispute resolution programs designed to resolve business issues and advance shared objectives by responding to marketplace concerns to create a better customer experience. To learn more about industry self-regulation, please visit: BBBNP.org

Blog

Enhancing Brand Safety: Understanding Self-Regulation vs. Independent Industry Self-Regulation

With copious amounts of content proliferating across a growing number of platforms and websites, it is an ongoing challenge for advertisers and platforms to ensure that digital ads are not placed next to harmful content. In this conversation, there is a key distinction few are making — the difference between ‘self-regulation’ and ‘independent, industry-wide self-regulation.’
Read more
Blog

CFBAI and CCAI Published the 2020 Annual Report on Participant Compliance and Program Progress

BBB National Programs has released the CFBAI and CCAI 2020 Annual Report, which includes findings on CFBAI and CCAI participant compliance with their commitment to advertise only foods that meet CFBAI’s strict Uniform Nutrition Criteria or to not engage in advertising primarily directed to children under age 12. The Report indicates excellent compliance by the 19 CFBAI participants and the eight CCAI participants in 2020.
Read more
Blog

What Do You Need to Know about the Florida Lemon Law?

If you have ever purchased or leased a car or SUV that you consider a lemon, you may have questions about the myriad of federal and state laws that govern your vehicle and the remedies available to you. Each state also has their own statute governing vehicles sold and leased in that state for personal use. Today, we look at the lemon law in Florida, one of the fastest-growing states in the U.S.
Read more
Blog

AI Can Be A Force For Good In Recruiting And Hiring New Employees

A challenge for rapid innovation in any industry is the ability for legal and regulatory requirements to keep pace. In the recruiting and hiring process, where AI provides aid to human decision-making and a welcome relief to managing a deluge of data, company leaders are asking themselves: How can we combine important technological innovation with a proactive approach to employment law requirements?
Read more

Advertiser Agrees to Refrain from Claims that Provezza Elderberry Syrup Protects Against COVID-19

For Immediate Release 

Contact: Abby Hills, Director of Communications, BBB National Programs 

301.412.7769 / ahills@bbbnp.org 

 

New York, NY – June 22, 2020 – Provezza Health, LLC informed the National Advertising Division (NAD) that, prior to the opening of NAD’s inquiry, it had permanently discontinued the Instagram post of Provezza Elderberry Syrup with the text, “Potent Immune Support During A Severe Season” and associated text stating “Provezza is highly concentrated to deliver antioxidant action for immune defense” because the advertisement’s publication cycle had ended. While the advertiser disagreed that the post challenged by NAD conveyed the implied claim that Provezza Elderberry Syrup protects users against COVID-19, it committed to refrain from making express or implied claims with such a message in the future.

Through a routine monitoring program, NAD questioned a social media post by Provezza Health, noting that the Federal Trade Commission (FTC) and the U.S. Food and Drug Administration (FDA) have issued dozens of warning letters to dietary supplement manufacturers in response to advertisements touting their products’ abilities to cure or increase consumers’ immunity to protect them from COVID-19. NAD shares the FTC and FDA’s concerns and is using its monitoring resources to find claims for products touting misleading health-conferring benefits related to COVID-19 as part of its public interest mission to protect consumers particularly during this unprecedented time.

NAD appreciated the advertiser’s cooperation and its commitment to avoid making any express or implied claims that promote its products’ ability to protect consumers against COVID-19 in future advertising.

In its advertiser’s statement, Provezza Health thanked NAD for “its ongoing monitoring efforts of the dietary supplement industry” and stated that it has “never expressly or impliedly claimed to treat COVID-19 or any other disease, and we will continue this policy in the future.”

This release was updated on June 26, 2020. Contact Abby Hills with questions. 

 

### 

About the National Advertising Division: National Advertising Division (NAD), a division of BBB National Programs, provides independent self-regulation overseeing the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for truth and accuracy.  

About BBB National Programs: BBB National Programs fosters trust, innovation, and competition in the marketplace through the development and delivery of cost-effective, third-party self-regulation, dispute resolution and other programs. BBB National Programs is the home of industry self-regulatory and dispute resolution programs designed to resolve business issues and advance shared objectives by responding to marketplace concerns to create a better customer experience. To learn more about industry self-regulation, please visit: BBBNP.org

 

 

Media Inquiry